- Home
- NL vs PRQR Comparison
NL vs PRQR Comparison
Compare NL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | PRQR |
|---|---|---|
| Founded | 1891 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | 187 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.1M | 262.5M |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NL | PRQR |
|---|---|---|
| Price | $6.53 | $1.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 36.2K | ★ 777.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 10.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $158,285,000.00 | N/A |
| Revenue This Year | $9.32 | N/A |
| Revenue Next Year | N/A | $13.92 |
| P/E Ratio | $24.89 | ★ N/A |
| Revenue Growth | ★ 8.46 | N/A |
| 52 Week Low | $5.04 | $1.33 |
| 52 Week High | $8.60 | $3.10 |
Technical Indicators
Market Signals| Indicator | NL | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 59.26 | 53.59 |
| Support Level | $5.67 | $1.37 |
| Resistance Level | $6.74 | $1.99 |
| Average True Range (ATR) | 0.26 | 0.10 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 74.68 | 55.88 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.